Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease

Puja K Mehta1, Odayme Quesada2, Ahmed Al-Badri1

  • 1Emory Women's Heart Center, Division of Cardiology, Emory University, Atlanta, GA, United States of America.

Insights

Patients with ischemia with no obstructive coronary artery disease (INOCA) face risks despite clear arteries. Early diagnosis of coronary microvascular dysfunction (CMD) is crucial for managing INOCA symptoms and improving outcomes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • A significant number of patients with suspected obstructive coronary artery disease (CAD) are diagnosed with ischemia with no obstructive coronary artery disease (INOCA).
  • INOCA patients face elevated risks for adverse cardiovascular events, recurrent chest pain, and reduced quality of life.
  • Coronary microvascular dysfunction (CMD) is a key contributor to adverse outcomes in INOCA, involving both endothelium-dependent and independent mechanisms.

Purpose of the Study:

  • To review current diagnostic methods for identifying functional abnormalities in INOCA.
  • To discuss treatment strategies for epicardial and/or microvascular dysfunction in INOCA patients.
  • To highlight the importance of functional testing in INOCA management.

Main Methods:

  • Review of current literature on diagnostic testing for INOCA.
  • Analysis of non-invasive and invasive functional testing approaches.
  • Examination of therapeutic interventions for CMD and epicardial dysfunction.

Main Results:

  • Traditional diagnostic tests often overlook functional abnormalities in INOCA.
  • Functional testing is essential for detecting coronary epicardial and microvascular dysfunction in INOCA.
  • CMD plays a significant role in the pathophysiology and adverse outcomes associated with INOCA.

Conclusions:

  • Patients with INOCA and persistent angina require functional assessment to detect epicardial and microvascular dysfunction.
  • Targeted treatment strategies for CMD are vital for improving patient outcomes.
  • Further research into diagnostic and therapeutic approaches for INOCA is warranted.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
53
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
111
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
63
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
77
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
61